As a parent of two young children with life-threatening food allergies, I carry an EpiPen with me at all times. It is literally the difference between life and death.

The recent news that Mylan Pharmaceuticals has escalated the price of this medication nearly 450 percent in the years since it took over production — from $50 for one injector to $600 for a pack of two — is outrageous. The ability to access lifesaving medicine should not be a matter of financial privilege.

Six hundred dollars is an obscene amount of money for medication that hasn’t experienced any marked improvement to justify a substantial price increase. Mylan has made this lifesaving medicine effectively inaccessible for millions of people for whom it’s meant to help. The company is ruthlessly preying on people who depend on EpiPens to live their daily lives.

In response to growing public pressure, Mylan has offered “coupons” for some people. It has also said it will now offer a generic version of the EpiPen (“Mylan Will Offer Lower-Cost Generic EpiPen Amid Outcry,” Aug. 30) for the bottom-barrel price of $300 per pack — still wildly out of reach for the majority of patients in need of the lifesaving medication. But not everyone will even have access to the lower-priced version; availability of generic medication is dependent upon the consumer’s health insurance policy and plans.

Advertise with us

Don’t be fooled — Mylan’s current PR strategy is hardly a solution to its entrenched practice of price gouging.

Thankfully, there are real solutions. To start, we must demand transparency from drug companies whose only concern seems to be their own profit margin. We can continue to expose their unscrupulous tactics and publicly demand that they provide explanations for increasing prices, not just sly marketing ploys meant to appease public outcry and repair their falling stock prices.

We must also call on Pennsylvania’s congressional representatives to explore mandatory drug pricing transparency as a solution. Pharmaceutical companies like Mylan need to know that EpiPens and other expensive drugs must be affordable and accessible for those who need them the most.

JODI HIRSH

Highland Park